# Bisphosphonates and Impaction Grafting in Hip Revision

> **NCT00658268** · PHASE2 · COMPLETED · sponsor: **Region Skane** · enrollment: 32 (actual)

## Conditions studied

- Aseptic Loosening of the Hip Prosthesis

## Interventions

- **DRUG:** Clodronate
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00658268
- **Lead sponsor:** Region Skane
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03
- **Primary completion:** 2017-08-01
- **Final completion:** 2017-08-01
- **Target enrollment:** 32 (ACTUAL)
- **Last updated:** 2017-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00658268

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00658268, "Bisphosphonates and Impaction Grafting in Hip Revision". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00658268. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*